Loading...

AMPH AMPHASTAR PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

MPHS

MPH

AMPHASTAR PHARMACEUTICALS INC

(AMPH)

2026 8-K

Share Buyback Increase

Executive Agreements

Supply Agreements Update

Financial Results Announcement

License Agreement Signed

Financial Results Announced

New Distribution Agreement

New Research Agreement

Financial Statements

Financial Statements

Financial Results

Q3 Earnings Report

Distribution Agreement

Financial Results Announcement

Annual Meeting and Share Bu...

Earnings Reports

Financial Results Announcement

Earnings Report

Purchase Agreement

Financial Results Announcement

Credit Agreement and Acquis...

Annual Meeting Voting Results

Financial Results Announcement

Asset Purchase Agreement

Amendment to Contract Resea...

Financial Results Announcement

Amended and Restated Bylaws...

External Links:

Amphastar Pharmaceuticals, Inc. announced on March 12, 2026, a $50 million increase to its share buyback program to offset dilution from equity compensation. The buyback will continue indefinitely, depending on various market factors.

AI Assistant

AMPHASTAR PHARMACEUTICALS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.